Michael Y. Choi
University of California, San Francisco(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Advanced Breast Cancer Therapies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells(2011)401 cited
- → Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial(2017)374 cited
- → Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study(2017)324 cited
- → Thrombospondins 1 and 2 are Necessary for Synaptic Plasticity and Functional Recovery after Stroke(2008)266 cited
- → Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia(2018)183 cited
- → Update on non-canonical microRNAs(2014)144 cited
- → Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy(2018)131 cited
- → Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy(2020)113 cited
- → Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1(2015)110 cited
- → A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development(2006)95 cited